Study identifies new target in treating mesothelioma

July 3, 2012, University of Hawaii at Manoa

July 1, 2012 cover of Cancer Research
(Medical Xpress) -- An international team of researchers, led by Haining Yang, PhD, from the University of Hawai‘i Cancer Center, has identified HMGB1 as a critical protein in the pathogenesis of malignant mesothelioma, one of the most dangerous forms of cancer highly related to asbestos and erionite exposure. The findings are featured as the cover story of the July 1, 2012 issue of Cancer Research, one of the nation's leading cancer research publications.

“We are very excited about this discovery and are extremely pleased that it was also chosen to be the featured cover story,” said Yang. “The next step is to translate this discovery into actual treatments for patients.”

The discovery outlines the process causing the growth of mesothelioma and offers scientists an opportunity to develop specific therapies for treatment. Mesothelioma is an aggressive cancer usually diagnosed at late stages and is resistant to current treatments. The average survival rate is less than one year. However, five percent of patients diagnosed at an early stage have survival rates of five to 10 years or more. The identification of this new biomarker for early detection will help shed light on developing novel targets for mesothelioma prevention and therapy.

Mesothelioma has been linked to occupational and environmental exposure to asbestos. Erionite, a naturally occurring mineral fiber, also causes mesothelioma. In the United States, approximately 3,000 cases of mesothelioma are diagnosed each year. It has been estimated that over 25 million people have been exposed to asbestos in the U.S., while the amount of those exposed to erionite is unknown.

The UH Cancer Center is a global leader in mesothelioma research. The center’s thoracic oncology team led by Director Michele Carbone, MD, PhD, and Yang, has also been instrumental in several other recent discoveries including the identification of the gene that causes mesothelioma, BAP1.

The current study was an international effort and included investigators from the University of Hawai‘i Cancer Center, the John A Burns School of Medicine in Honolulu, the San Raffaele University and Research Institute in Milan, Italy, the National Institutes of Health in Bethesda, Md., and the New York University School of Medicine.

Explore further: Scientists find genetic link to mesothelioma

Related Stories

Scientists find genetic link to mesothelioma

August 28, 2011
Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer – mesothelioma, and melanoma of the eye. Additionally, when these individuals are exposed ...

New study finds cancer-causing mineral in US road gravel

July 25, 2011
As school buses drive down the gravel roads in Dunn County, North Dakota, they stir up more than dirt. The clouds of dust left in their wake contain such high levels of the mineral erionite that those who breathe in the air ...

Exposure to North Dakota road material may increase risk of lung cancer

December 9, 2010
New data shows that people exposed to the mineral erionite found in the gravel of road materials in North Dakota may be at significantly increased risk of developing mesothelioma, a type of lung cancer most often associated ...

Mystery unraveled: How asbestos causes cancer

June 29, 2010
More than 20 million people in the U.S., and many more worldwide, who have been exposed to asbestos are at risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen that is resistant ...

Renal cancer drug temsirolimus shows promise against mesothelioma

May 1, 2011
A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.

Photodynamic therapy added to lung-sparing surgery improves survival for mesothelioma patients

May 30, 2012
(Medical Xpress) -- Among patients with malignant pleural mesothelioma, treatment with lung-sparing surgery in combination with photodynamic therapy (PDT) yielded unusually long survival rates, with median survival rates ...

Recommended for you

Obesity both feeds tumors and helps immunotherapy kill cancer

November 12, 2018
A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors.

Spread of deadly eye cancer halted in cells and animals

November 12, 2018
By comparing genetic sequences in the eye tumors of children whose cancers spread with tumors that didn't spread, Johns Hopkins Medicine researchers report new evidence that a domino effect in cells is responsible for the ...

Cancer stem cells get energy from protein, and it's proving to be their Achilles' heel

November 12, 2018
Think of energy metabolism like a party popper: Ripping something apart releases a bang. Most of your cells rip apart sugar to release the "bang" of energy. Sometimes they rip apart fats, and in a pinch, cells can even metabolize ...

Scientists shine new light on link between obesity and cancer

November 12, 2018
Scientists have made a major discovery that shines a new, explanatory light on the link between obesity and cancer. Their research confirms why the body's immune surveillance systems—led by cancer-fighting Natural Killer ...

Two-pronged device enables maverick immune cells to identify and kill cancers

November 12, 2018
Immune cells called Gamma Delta T cells can act independently to identify and kill cancer cells, defying the conventional view of the immune system, reveals new research from the Francis Crick Institute and King's College ...

Research brings personalized medicine to treat leukemia one step closer

November 12, 2018
Scientists at the University of Birmingham have revealed the roles that different types of gene mutations play in causing blood cancers in a study that was the culmination of a decade's research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.